Entero Healthcare Solutions Ltd
Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India[1]
- Market Cap ₹ 4,850 Cr.
- Current Price ₹ 1,118
- High / Low ₹ 1,258 / 970
- Stock P/E 126
- Book Value ₹ 374
- Dividend Yield 0.00 %
- ROCE 3.99 %
- ROE 4.97 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Stock is trading at 2.99 times its book value
- Earnings include an other income of Rs.89.9 Cr.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| 105 | 137 | 178 | 318 | |
| 137 | 191 | 222 | 353 | |
| Operating Profit | -32 | -54 | -44 | -34 |
| OPM % | -30% | -39% | -25% | -11% |
| 23 | 27 | 53 | 90 | |
| Interest | 2 | 5 | 11 | 22 |
| Depreciation | 7 | 9 | 10 | 9 |
| Profit before tax | -18 | -41 | -12 | 24 |
| Tax % | 0% | 0% | 0% | -58% |
| -18 | -41 | -12 | 38 | |
| EPS in Rs | -1,811.38 | -106.10 | -30.31 | 8.84 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 45% |
| TTM: | 79% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 60% |
| TTM: | 409% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 5% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Equity Capital | 0 | 4 | 4 | 43 |
| Reserves | -31 | -72 | -84 | 1,583 |
| 540 | 674 | 775 | 18 | |
| 23 | 47 | 68 | 125 | |
| Total Liabilities | 533 | 654 | 764 | 1,769 |
| 50 | 51 | 41 | 34 | |
| CWIP | 2 | 0 | 0 | 0 |
| Investments | 39 | 39 | 41 | 41 |
| 442 | 563 | 682 | 1,694 | |
| Total Assets | 533 | 654 | 764 | 1,769 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| -68 | -45 | -57 | -76 | |
| -7 | -69 | -58 | -763 | |
| 76 | 127 | 91 | 926 | |
| Net Cash Flow | 0 | 14 | -24 | 87 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Debtor Days | 107 | 139 | 153 | 130 |
| Inventory Days | 177 | 103 | 68 | 65 |
| Days Payable | 48 | 99 | 132 | 88 |
| Cash Conversion Cycle | 236 | 143 | 89 | 107 |
| Working Capital Days | 1,210 | 1,123 | 1,086 | 855 |
| ROCE % | -6% | -0% | 4% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15 Jul - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR), Regulations 2015.
-
Announcement under Regulation 30 (LODR)-Acquisition
28 Jun - Entero Healthcare Solutions Limited ("Entero") has informed about acquisition of Devi Pharma Wellness Private Limited approved by the Board of Entero at its meeting held …
- Board Meeting Outcome for Outcome Of Board Meeting Held On June 28, 2024 28 Jun
- Closure of Trading Window 27 Jun
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18 Jun - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR), Regulations 2015
Concalls
-
Jun 2024Transcript PPT REC
-
May 2024TranscriptNotesPPT
-
Mar 2024Transcript PPT
Leading Healthcare Product Disributor[1] The company is among the top three healthcare distributors in India in terms of revenue. Further, it achieved the fastest scale-up of operations among healthcare product distributors in India between FY19 - FY22.